109 related articles for article (PubMed ID: 5403005)
1. [Cases of multiple sclerosis with gammagraphic pseudotumoral signs].
Bady B; Trillet M; Boucher M; Gallade
Rev Otoneuroophtalmol; 1969 Nov; 41(7):369-73. PubMed ID: 5403005
[No Abstract] [Full Text] [Related]
2. [Suspected multiple sclerosis].
Pellkofer H; Hohlfeld R
MMW Fortschr Med; 2006 Mar; 148(13):63-4. PubMed ID: 16642711
[No Abstract] [Full Text] [Related]
3. [Immunosuppressive therapy and humoral immunity in multiple sclerosis].
Mavra M
Srp Arh Celok Lek; 1980 Nov; 108(11):1139-48. PubMed ID: 7313825
[No Abstract] [Full Text] [Related]
4. The value of magnetic resonance imaging in diagnosis and monitoring of treatment in multiple sclerosis.
Bekiesińska-Figatowska M; Walecki J; Stelmasiak Z
Acta Neurobiol Exp (Wars); 1996; 56(1):171-6. PubMed ID: 8787171
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive therapy in multiple sclerosis.
Edan G
Neurol Sci; 2005 May; 26 Suppl 1():S18. PubMed ID: 15883680
[No Abstract] [Full Text] [Related]
6. [Diagnostics and drug therapy of multiple sclerosis].
Suomen Neurologinen Yhdistys ry
Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
[No Abstract] [Full Text] [Related]
7. [Methodologic and ethical implications of immunosuppressive therapy in multiple sclerosis].
Szobor A
Orv Hetil; 1984 Mar; 125(11):673. PubMed ID: 6700975
[No Abstract] [Full Text] [Related]
8. [Status and perspective in the therapy of multiple sclerosis. C. Prevention of relapses and of progression].
Pöhlau D
Krankenpfl J; 1997 Mar; 35(3):69-71. PubMed ID: 9136384
[No Abstract] [Full Text] [Related]
9. [Immunosuppressive medication in multiple sclerosis].
García Merino JA
Rev Neurol; 2002 Dec 16-31; 35(12):1154-8. PubMed ID: 12497298
[TBL] [Abstract][Full Text] [Related]
10. [Multiple sclerosis].
Offenhäusser M; Martin R
Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627
[No Abstract] [Full Text] [Related]
11. [Multiple sclerosis--current status of therapy].
Reichel D; Kölmel HW
Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
[TBL] [Abstract][Full Text] [Related]
12. [Experiences with the indirect Clausen Test using NTA as an antigen in multiple sclerosis and other neurologic diseases].
Dachsel R; Felber F; Liebert A
Psychiatr Neurol Med Psychol (Leipz); 1984 Jun; 36(6):350-6. PubMed ID: 6484061
[TBL] [Abstract][Full Text] [Related]
13. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Frohman EM; Havrdova E; Lublin F; Barkhof F; Achiron A; Sharief MK; Stuve O; Racke MK; Steinman L; Weiner H; Olek M; Zivadinov R; Corboy J; Raine C; Cutter G; Richert J; Filippi M
Arch Neurol; 2006 Apr; 63(4):614-9. PubMed ID: 16606781
[No Abstract] [Full Text] [Related]
14. Immunopathogenesis of multiple sclerosis: implications for treatment.
Waldron-Lynch F; Hennessy MJ
Ir Med J; 2004 Jan; 97(1):5-6. PubMed ID: 15055909
[No Abstract] [Full Text] [Related]
15. [Multiple sclerosis: from immunopathogenesis to disease management].
Nervenarzt; 1996 Dec; 67(12 Suppl Von Der Im):1-8. PubMed ID: 9403091
[No Abstract] [Full Text] [Related]
16. Tumor-like presentation of multiple sclerosis.
Al-Bunyan MA
Saudi Med J; 2000 Apr; 21(4):393-5. PubMed ID: 11533828
[TBL] [Abstract][Full Text] [Related]
17. [Advantages in diagnostic and treatment of MS].
Hjaltason H
Laeknabladid; 2008 May; 94(5):359. PubMed ID: 18460730
[No Abstract] [Full Text] [Related]
18. [Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid].
Danielczyk W
Wien Med Wochenschr; 1968 Nov; 118(44):934-7. PubMed ID: 5710171
[No Abstract] [Full Text] [Related]
19. [Therapy of multiple sclerosis].
Simó M
Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
[TBL] [Abstract][Full Text] [Related]
20. Treatment of children and adolescents with multiple sclerosis.
Banwell B
Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
